newsfilter
← Latest News
Business Wire·

Pear Therapeutics Files for Chapter 11 and Will Seek to Sell Assets Through Sales Process

Pear Therapeutics, Inc. (NASDAQ:PEAR) ("the Company"), a company focused on developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced that the Company and